Home > Events > Past Conferences > Meeting of the Medical Imaging Drugs Advisory Committee Meeting Announcement

Meeting of the Medical Imaging Drugs Advisory Committee Meeting Announcement

The committee will discuss new drug application 212123, flortaucipir F18 intravenous injection, a radioactive diagnostic agent, submitted by Avid Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, for positron emission tomography imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles of Alzheimer’s disease.

Spotlight


OTHER PAST CONFERENCES

4th Annual Pharma AI Summit

October 26-27, 2023 | UK

Artificial Intelligence promises vast opportunities for economic and societal benefits in the pharmaceutical industry, life sciences and healthcare including care delivery with digital health. As data applications supported by AI become more advanced, the whole healthcare value chain has been affected. New forms of drug discoveries and pharma workforces are going to evolve.

World Congress on Pharmacology and Drug Safety WCPDS

October 9-10, 2023 | USA

The World Congress on Pharmacology and Drug Safety WCPDS. It will be held on 09th - 10th-Oct-2023 at New Orleans, USA. WCPDS and is being organized by IIERD to provide an opportunity to research scholars, delegates and students to interact and share their experience and knowledge in technology application.

2023 ISPE Annual Meeting & Expo

October 15-18, 2023 | USA

Hosted by the International Society for Pharmaceutical Engineering, the 2023 ISPE Annual Meeting is designed to bring together pharma professionals to discuss developments across the pharma manufacturing lifecycle.

Pharmacovigilance World 2023

November 1-2, 2023 | UK

The Pharmacovigilance World 2023 will provide a platform for the participants to discuss, share and stay updated with present state of affairs in Pharmacovigilance and Drug safety, and how it contributes to the public health.

4th Annual Pharma AI Summit

October 26-27, 2023 | UK

Artificial Intelligence promises vast opportunities for economic and societal benefits in the pharmaceutical industry, life sciences and healthcare including care delivery with digital health. As data applications supported by AI become more advanced, the whole healthcare value chain has been affected. New forms of drug discoveries and pharma workforces are going to evolve.

World Congress on Pharmacology and Drug Safety WCPDS

October 9-10, 2023 | USA

The World Congress on Pharmacology and Drug Safety WCPDS. It will be held on 09th - 10th-Oct-2023 at New Orleans, USA. WCPDS and is being organized by IIERD to provide an opportunity to research scholars, delegates and students to interact and share their experience and knowledge in technology application.

2023 ISPE Annual Meeting & Expo

October 15-18, 2023 | USA

Hosted by the International Society for Pharmaceutical Engineering, the 2023 ISPE Annual Meeting is designed to bring together pharma professionals to discuss developments across the pharma manufacturing lifecycle.

Pharmacovigilance World 2023

November 1-2, 2023 | UK

The Pharmacovigilance World 2023 will provide a platform for the participants to discuss, share and stay updated with present state of affairs in Pharmacovigilance and Drug safety, and how it contributes to the public health.
More Past Conferences

Spotlight

resources

resource image

How long will the world wait for the next pandemic of antimicrobial resistance before we act?

Article

resource image

The Cardinal Health™ InteLogix™ Platform

video

resource image

Driving Down Drug Costs: How Real-Time Transparency in PBMs Can Make a Difference

Article